Redirect Notice

Looks like you clickedhttps://cllsociety.org/2022/08/we-need-your-help-the-fda-will-be-reviewing-whether-duvelisib-should-be-withdrawn-or-continue-to-be-approved-for-relapsed-refractory-cll/

If you do not want to visit that page, you can close this browser tab.